Market Access Views & Analysis

Views & Analysis

Market Access

The latest Board moves reflect a focus on experience in commercialisation, corporate governance, and therapeutic development.

Market Access

At PPIC in Basel, pharma pricing experts discussed how policy changes and AI advances are altering the dynamics of pharmaceutical pricing and access.

Market Access

Acumetis is a global expert commercialisation partner purposefully built to help life sciences companies win in the age of connectivity.

Market Access

Finding a start-up or building an app is the cheap part; combining capabilities into something that scales across markets is the expensive part.

Market Access

Under the VPAG agreement, £400 million is available under the VPAG Investment Fund. But what benefits will stay once funding goes away in 2029?

Market Access

The global pharmaceutical landscape is increasingly defined by the necessity for clinical acceleration without compromising data integrity.